Quick Answer
Citius Pharmaceuticals, Inc. reported Stockholders Equity of $67.55 million for fiscal year 2025.
Citius Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $67.55M | -3.6% |
| 2024 | $70.08M | -22.8% |
| 2023 | $90.83M | -11.7% |
| 2022 | $102.83M | -22.2% |
| 2021 | $132.18M | +292.6% |
| 2020 | $33.67M | +24.0% |
| 2019 | $27.15M | -11.4% |
| 2018 | $30.64M | +39.6% |
| 2017 | $21.95M | +30.9% |
| 2016 | $16.77M | +2739.5% |
| 2015 | -$635.2K | +14.4% |
| 2014 | -$741.9K | +74.4% |
| 2013 | -$2.90M | -19647.9% |
| 2013 | -$14.7K | +99.1% |
| 2012 | -$1.61M | -3419.9% |
| 2012 | -$45.8K | -92.3% |
| 2011 | -$23.8K | +0.0% |
| 2011 | -$23.8K | -1053.6% |
| 2010 | $2.5K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $79.96M | +22.2% | +18.4% |
| September 30, 2025 | $67.55M | -3.6% | +3.8% |
| June 30, 2025 | $65.06M | -24.1% | +7.3% |
| March 31, 2025 | $60.66M | -23.6% | -7.3% |
| December 31, 2024 | $65.41M | -22.8% | -6.7% |
| September 30, 2024 | $70.08M | -22.8% | -18.2% |
| June 30, 2024 | $85.68M | -12.3% | +8.0% |
| March 31, 2024 | $79.37M | -13.0% | -6.3% |
- Citius Pharmaceuticals, Inc. showed a decrease of -3.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, Citius Pharmaceuticals, Inc.’s stockholders equity has grown by 2701907.1% (from $2.5 thousand to $67.55 million).
- The most recent figure is from Citius Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: